4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol

Metabolite details

Identifier

UCTWMZQNUQWSLP-UHFFFAOYSA-N

InChI Key

UCTWMZQNUQWSLP-UHFFFAOYSA-N

IUPAC name

4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol

Preferred name

4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol

INN name

—

Synonym

—

ChEBI

CHEBI:194548

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Brain tissue metabolomics)
• Sodium Butyrate mediates Histone Crotonylation and Alleviated Neonatal Rats Hypoxic-Ischemic Brain Injury Through Gut-Brain Axis (untargeted fecal metabolomics)
• Metabolome analysis reveal key regulatory pathways of feed conversion efficiency of oriental river prawn Macrobrachium nipponense
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_vs_Neural_Tube_Defect
• Normal_vs_Neural_Tube_Defect
• Sham_vs_HIBD
• HRFI_Hepatopancreas_vs_LRFI_Hepatopancreas
• wild_type_vs_patA_deletion
• Control_vs_BP3_Low_Concentration